Cargando…

ESC Working Group Cellular Biology of the Heart: Position Paper: improving the preclinical assessment of novel cardioprotective therapies

Ischaemic heart disease (IHD) remains the leading cause of death and disability worldwide. As a result, novel therapies are still needed to protect the heart from the detrimental effects of acute ischaemia–reperfusion injury, in order to improve clinical outcomes in IHD patients. In this regard, alt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lecour, Sandrine, Bøtker, Hans E., Condorelli, Gianluigi, Davidson, Sean M., Garcia-Dorado, David, Engel, Felix B., Ferdinandy, Peter, Heusch, Gerd, Madonna, Rosalinda, Ovize, Michel, Ruiz-Meana, Marisol, Schulz, Rainer, Sluijter, Joost P.G., Van Laake, Linda W., Yellon, Derek M., Hausenloy, Derek J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	Topical Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242141/ https://www.ncbi.nlm.nih.gov/pubmed/25344369 http://dx.doi.org/10.1093/cvr/cvu225

Ejemplares similares

IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action
por: Lecour, Sandrine, et al.
Publicado: (2021)

Co‐morbidities and co‐medications as confounders of cardioprotection—Does it matter in the clinical setting?
por: Kleinbongard, Petra, et al.
Publicado: (2020)

Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning
por: Ferdinandy, Péter, et al.
Publicado: (2023)

Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations
por: Hausenloy, Derek J., et al.
Publicado: (2010)

Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection
por: Bøtker, Hans Erik, et al.
Publicado: (2018)

Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations
por: Hausenloy, Derek J., et al.
Publicado: (2017)

ESC Joint Working Groups on Cardiovascular Surgery and the Cellular Biology of the Heart Position Paper: Peri-operative myocardial injury and infarction in patients undergoing coronary artery bypass graft surgery
por: Thielmann, Matthias, et al.
Publicado: (2017)

Translational issues for mitoprotective agents as adjunct to reperfusion therapy in patients with ST‐segment elevation myocardial infarction
por: Bøtker, Hans Erik, et al.
Publicado: (2020)

Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardioprotection
por: Heusch, Gerd, et al.
Publicado: (2023)

Epigenomic and transcriptomic approaches in the post-genomic era: path to novel targets for diagnosis and therapy of the ischaemic heart? Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart
por: Perrino, Cinzia, et al.
Publicado: (2017)

Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery
por: Hausenloy, Derek J., et al.
Publicado: (2016)

The novel adipocytokine visfatin exerts direct cardioprotective effects
por: Lim, Shiang Y, et al.
Publicado: (2008)

Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology
por: Sluijter, Joost Petrus Gerardus, et al.
Publicado: (2018)

Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI)
por: Bulluck, Heerajnarain, et al.
Publicado: (2021)

Exosomes and cardioprotection – A critical analysis
por: Davidson, Sean M., et al.
Publicado: (2018)

Focus on 2010 ESC Congress
Publicado: (2010)

Highlights form ESC 2015
por: Tokgözoğlu, Prof. Lale
Publicado: (2015)

STAT5 fits the RISK profile for cardioprotection
por: Davidson, Sean M., et al.
Publicado: (2012)

9th Hatter Biannual Meeting: position document on ischaemia/reperfusion injury, conditioning and the ten commandments of cardioprotection
por: Bell, R. M., et al.
Publicado: (2016)

The importance of clinically relevant background therapy in cardioprotective studies
por: He, Zhenhe, et al.
Publicado: (2020)

Role of Macrophages in Cardioprotection
por: Yap, Jonathan, et al.
Publicado: (2019)

The 10th Biennial Hatter Cardiovascular Institute workshop: cellular protection—evaluating new directions in the setting of myocardial infarction, ischaemic stroke, and cardio-oncology
por: Davidson, Sean M., et al.
Publicado: (2018)

The RISK pathway leading to mitochondria and cardioprotection: how everything started
por: Yellon, Derek M., et al.
Publicado: (2023)

Targeting mitochondrial fusion and fission proteins for cardioprotection
por: Hernandez‐Resendiz, Sauri, et al.
Publicado: (2020)

Parkinson's disease proteins: Novel mitochondrial targets for cardioprotection
por: Mukherjee, Uma A., et al.
Publicado: (2015)

Reducing myocardial infarct size: challenges and future opportunities
por: Bulluck, Heerajnarain, et al.
Publicado: (2016)

The GTN patch: a simple and effective new approach to cardioprotection?
por: Yellon, Derek M., et al.
Publicado: (2018)

ESC 2019 guidelines for the diagnosis and management of chronic coronary syndromes: Recommendations for cardiovascular imaging
por: Saraste, Antti, et al.
Publicado: (2020)

Remote ischemic conditioning: from experimental observation to clinical application: report from the 8th Biennial Hatter Cardiovascular Institute Workshop
por: Pickard, Jack M. J., et al.
Publicado: (2014)

Mitochondria in acute myocardial infarction and cardioprotection
por: Ramachandra, Chrishan J.A., et al.
Publicado: (2020)

What we have learned from the ESC position paper on arrhythmias in acute coronary syndromes
por: Görenek, Bülent, et al.
Publicado: (2015)

Wake Up and Smell the Coffee: Yet Another No Go for Cardiac Patients?: Editorial to “Caffeinated Coffee Blunts the Myocardial Protective Effects of Statins Against Ischemia–reperfusion Injury in the Rat” by Ye et al.
por: Riksen, Niels P., et al.
Publicado: (2008)

Influence of mental stress and environmental toxins on circadian clocks: Implications for redox regulation of the heart and cardioprotection
por: Li, Huige, et al.
Publicado: (2020)

Cardioprotective effect of combination therapy by mild hypothermia and local or remote ischemic preconditioning in isolated rat hearts
por: Hjortbak, Marie V., et al.
Publicado: (2021)

Mitochondrial ion channels as targets for cardioprotection
por: Hausenloy, Derek J., et al.
Publicado: (2020)

The role of PI3Kα isoform in cardioprotection
por: Rossello, Xavier, et al.
Publicado: (2017)

Is it the time of seno-therapeutics application in cardiovascular pathological conditions related to ageing?
por: Balistreri, Carmela Rita, et al.
Publicado: (2021)

Cardioprotective and anti-hypertensive effects of Prosopis glandulosa in rat models of pre-diabetes
por: Huisamen, B, et al.
Publicado: (2013)

RAAS INHIBITORS ARE CARDIOPROTECTIVE IN PATIENTS WITH COVID-19
por: Holmes, Adam R., et al.
Publicado: (2021)

Diazoxide is a powerful cardioprotectant but is not feasible in a realistic infarct scenario
por: Kleinbongard, Petra, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_op2svvhls5590vhhr0q2j36mlm